"Environmental risk factors associated with juvenile idiopathic arthritis associated uveitis: a systematic review of the literature".
Allergy
Environment
Juvenile idiopathic arthritis
Risk factors
Season
Uveitis
Vitamin D
Journal
Journal of ophthalmic inflammation and infection
ISSN: 1869-5760
Titre abrégé: J Ophthalmic Inflamm Infect
Pays: Germany
ID NLM: 101553216
Informations de publication
Date de publication:
24 May 2021
24 May 2021
Historique:
received:
04
03
2021
accepted:
10
05
2021
entrez:
24
5
2021
pubmed:
25
5
2021
medline:
25
5
2021
Statut:
epublish
Résumé
Juvenile idiopathic arthritis associated uveitis (JIA-U) is the most common extra-articular manifestation of juvenile idiopathic arthritis (JIA) and carries considerable risk to vision. The aim of this systematic review was to synthesise evidence of environmental risk factors for JIA-U and identify risk factors which may be modifiable or used to stratify JIA patients. This systematic review was carried out in accordance with PRISMA guidelines. Four online databases - Cumulative Index of Nursing and Allied Health Literature, Web of Science, MEDLINE and Embase - were searched from database inception to 12th August 2020. Identified studies were screened by two independent reviewers against pre-defined inclusion and exclusion criteria. Data was extracted from all primary studies meeting inclusion criteria and independently checked. We identified three studies from 895 unique records which met the inclusion criteria, each examining a different environmental risk factor. This systematic review includes 973, predominantly female, participants with JIA across these three studies. The use of allergy medication or documentation of "allergy"/"allergic" in the medical records was associated with an increased risk of JIA-U in all models presented. Vitamin D sufficiency was associated with reduced risk of JIA-U. There was insufficient evidence to support an association between seasonality and JIA-U. This review identifies a potential role for allergy and vitamin D in JIA-U. It also illustrates the paucity of data regarding environmental risk factors for JIA-U and highlights the need for further research to both identify additional risk factors and replicate existing findings.
Sections du résumé
BACKGROUND
BACKGROUND
Juvenile idiopathic arthritis associated uveitis (JIA-U) is the most common extra-articular manifestation of juvenile idiopathic arthritis (JIA) and carries considerable risk to vision. The aim of this systematic review was to synthesise evidence of environmental risk factors for JIA-U and identify risk factors which may be modifiable or used to stratify JIA patients.
METHODS
METHODS
This systematic review was carried out in accordance with PRISMA guidelines. Four online databases - Cumulative Index of Nursing and Allied Health Literature, Web of Science, MEDLINE and Embase - were searched from database inception to 12th August 2020. Identified studies were screened by two independent reviewers against pre-defined inclusion and exclusion criteria. Data was extracted from all primary studies meeting inclusion criteria and independently checked.
RESULTS
RESULTS
We identified three studies from 895 unique records which met the inclusion criteria, each examining a different environmental risk factor. This systematic review includes 973, predominantly female, participants with JIA across these three studies. The use of allergy medication or documentation of "allergy"/"allergic" in the medical records was associated with an increased risk of JIA-U in all models presented. Vitamin D sufficiency was associated with reduced risk of JIA-U. There was insufficient evidence to support an association between seasonality and JIA-U.
CONCLUSIONS
CONCLUSIONS
This review identifies a potential role for allergy and vitamin D in JIA-U. It also illustrates the paucity of data regarding environmental risk factors for JIA-U and highlights the need for further research to both identify additional risk factors and replicate existing findings.
Identifiants
pubmed: 34027581
doi: 10.1186/s12348-021-00247-1
pii: 10.1186/s12348-021-00247-1
pmc: PMC8141477
doi:
Types de publication
Journal Article
Langues
eng
Pagination
15Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S009310/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/5
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203918/Z/16/Z
Pays : United Kingdom
Références
Joint Bone Spine. 2019 Nov;86(6):685-690
pubmed: 31207292
Immunol Res. 1999;20(2):147-61
pubmed: 10580639
Pediatr Rheumatol Online J. 2013 Dec 03;11(1):45
pubmed: 24299016
Ophthalmology. 2001 Nov;108(11):2071-5
pubmed: 11713082
Am J Epidemiol. 2014 Apr 1;179(7):864-74
pubmed: 24573539
J Rheumatol. 2002 Nov;29(11):2446-53
pubmed: 12415607
Arthritis Res Ther. 2018 Dec 13;20(1):276
pubmed: 30545399
J Rheumatol. 2013 Dec;40(12):2088-96
pubmed: 24187099
JAMA Ophthalmol. 2018 May 1;136(5):548-552
pubmed: 29621365
Rheumatology (Oxford). 2002 Dec;41(12):1440-3
pubmed: 12468827
Eur Respir J. 2019 Nov 14;54(5):
pubmed: 31413164
Pediatr Rheumatol Online J. 2016 Apr 27;14(1):27
pubmed: 27121190
Clin Immunol. 2020 Feb;211:108322
pubmed: 31830532
Open Access Rheumatol. 2019 Nov 06;11:253-267
pubmed: 31807094
Rheumatology (Oxford). 2007 Jun;46(6):1015-9
pubmed: 17403710
Surv Ophthalmol. 2014 Sep-Oct;59(5):517-31
pubmed: 25130893
Arthritis Rheum. 2005 Feb;52(2):382-5
pubmed: 15692991
Autoimmun Rev. 2019 Sep;18(9):102350
pubmed: 31323357
J Autoimmun. 2017 Aug;82:13-30
pubmed: 28624334
J Immunol. 1986 Apr 1;136(7):2348-57
pubmed: 2419430
Viruses. 2019 Aug 19;11(8):
pubmed: 31430946
Arthritis Rheumatol. 2018 Jul;70(7):1155-1165
pubmed: 29513936
Eur Respir J. 1996 Dec;9(12):2630-4
pubmed: 8980980
Nat Med. 2007 Feb;13(2):139-45
pubmed: 17290272
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
J Ophthalmol. 2014;2014:461078
pubmed: 24701346
J Infect Dis. 1982 Jul;146(1):103-8
pubmed: 6282988
J Clin Epidemiol. 2009 Oct;62(10):1006-12
pubmed: 19631508